If there is one thing we have learned about this wacky world of ours is change comes slowly and typically only happens when it must happen. We are living through several examples of this as we speak. Johnson and Johnson (NYSE: JNJ) is desperately trying to sell their diabetes device franchise, and after the news earlier this week they may as well through in Invokana. JNJ is not making this change because business is great so they can get top dollar, they missed that opportunity years ago. They are selling because the business does continue to throw off cash, LifeScan . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.